Description
Contents
Perindopril/Indapamide
Indications/Uses
Treatment of essential hypertension in adults, Coversyl Plus 5 mg/1.25 mg film-coated tablet is indicated in patients whose blood pressure is not adequately controlled on perindopril alone.
Dosage/Direction for Use
Posology: One Coversyl Plus 5mg/1.25mg film-coated tablet per day as a single dose, preferably to be taken in the morning, and before a meal.
When possible individual dose titration with the components is recommended. Coversyl Plus 5mg/1.25mg film-coated tablet should be used when blood pressure is not adequately controlled on Preterax 2.5mg/0.625mg film-coated tablet (where available).When clinically appropriate, direct change from monotherapy to Coversyl Plus 5mg/1.25mg film-coated tablet may be considered.
Special populations: Elderly (see Precautions): Treatment should be initiated after considering blood pressure response and renal function.
Renal impairment (see Precautions): In severe renal impairment (creatinine clearance below 30 ml/min), treatment is contraindicated.
In patients with moderate renal impairment (creatinine clearance 30-60 ml/min), it is recommended to start treatment with the adequate dosage of the free combination.
In patients with creatinine clearance greater than or equal to 60 ml/min, no dose modification is required.
When possible individual dose titration with the components is recommended. Coversyl Plus 5mg/1.25mg film-coated tablet should be used when blood pressure is not adequately controlled on Preterax 2.5mg/0.625mg film-coated tablet (where available).When clinically appropriate, direct change from monotherapy to Coversyl Plus 5mg/1.25mg film-coated tablet may be considered.
Special populations: Elderly (see Precautions): Treatment should be initiated after considering blood pressure response and renal function.
Renal impairment (see Precautions): In severe renal impairment (creatinine clearance below 30 ml/min), treatment is contraindicated.
In patients with moderate renal impairment (creatinine clearance 30-60 ml/min), it is recommended to start treatment with the adequate dosage of the free combination.
In patients with creatinine clearance greater than or equal to 60 ml/min, no dose modification is required.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
